The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in adults.
Published: May 4, 2021 at 08:34PM
from NYT Health https://ift.tt/2SlHgzL
The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in adults.
Published: May 4, 2021 at 08:34PM
from NYT Health https://ift.tt/2SlHgzL